Multiple sclerosis (MS), a chronic inflammatory demyelinating disease of the central nervous
system, is one of the most common neurodegenerative diseases worldwide. MS results in …

Given the rapid increase of patients with autoimmune diseases and the lack of satisfactory
therapies, the discovery of novel and effective therapeutic targets have been in an urgent …

Background Previous studies have demonstrated that long noncoding RNA cancer
susceptibility candidate 2 (lncRNA CASC2) is frequently downregulated in several types of …

Studies have revealed that dysregulation in gene expression is one of the main aspects of
multiple sclerosis (MS) pathogenesis. Although the molecular pathways underlying the …

Myasthenia gravis (MG) is a cell‐dependent autoimmune disease commonly associated
with thymic pathology. Metastasis‐associated lung adenocarcinoma transcript 1 (MALAT‐1) …

Introduction Multiple sclerosis (MS) is a disease that causes progressive neurological
disability. Treatments are available that are protective against MS relapses and it is thought …

The long-term chronic inflammation of cervical intraepithelial neoplasia (CIN) induces the
initiation and progression of cervical cancer. Long non-coding RNAs (LncRNAs) are being …

Gliomas are the most common primary malignant tumor in the adult central nervous system
with poor prognosis. Exploring novel biomarkers and elucidating underlying molecular …

Background: In recent decades, the incidence of obesity has been rising globally. Obesity
can often cause various inflammatory reactions, resulting in several diseases that threaten …

Multiple sclerosis (MS) is a chronic inflammatory and autoimmune disorder of the central
nervous system characterized by myelin loss and axonal dysfunction. Increased production …